| HOME >> BIOLOGY >> TECHNOLOGY |
MERCERVILLE, N.J., Oct. 22 /PRNewswire-FirstCall/ -- Laser Energetics, Inc. (Pink Sheets: LNGT) announced today that the Company has entered into discussions with several medical and dental instrument suppliers regarding the integration of LEI's BrightStar(TM) Alexandrite lasers into their medical and dental products.
LEI's BrightStar(TM) Alexandrite laser's shorter fundamental tunable laser output and fiber optic beam delivery system can enhance medical and dental laser applications. The lasers may be used in the medical market for Photo Acoustic Imaging to detect certain types of cancer (such as breast cancer), Photo Dynamic Therapy for treatment of certain types of cancer (i.e., lung cancer), hair removal, tattoo removal, spider vein treatment, ophthalmic applications, and blood clot detection to name just a few applications. In addition, the lasers can be used in the dental market for low trauma decay treatment and teeth cleaning. There are many more medical and dental laser applications that LEI's BrightStar(TM) Alexandrite lasers can address.
The Company's BrightStar(TM) Alexandrite lasers, because of their compact design, are cheaper to build, and thus more cost effective and profitable to the practitioners using them.
These applications are in addition to the defense and homeland security markets already being addressed by the Company.
LEI's Medical Director, Dr. John T. LiVecchi, MD, FACS, stated "Lasers play a prominent role in the efficient delivery of healthcare in today's environment. Our BrightStar(TM) Alexandrite lasers are perfectly positioned to take a significant percentage of this large and growing market."
Robert D. Battis, Chairman and Chief Executive Officer of Laser
Energetics, said, "Our goal is to identify as many uses as possible for the
various BrightStar(TM) Alexandrite lasers. This will bring about cost
reduction in manufacturing, enhanced market share and increased profit
margins. LEI will strategica
'/>"/>
| SOURCE Laser Energetics, Inc. Copyright©2007 PR Newswire. All rights reserved |